1. Home
  2. LCUT vs LPTX Comparison

LCUT vs LPTX Comparison

Compare LCUT & LPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCUT
  • LPTX
  • Stock Information
  • Founded
  • LCUT 1945
  • LPTX 2011
  • Country
  • LCUT United States
  • LPTX United States
  • Employees
  • LCUT N/A
  • LPTX N/A
  • Industry
  • LCUT Industrial Machinery/Components
  • LPTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LCUT Consumer Discretionary
  • LPTX Health Care
  • Exchange
  • LCUT Nasdaq
  • LPTX Nasdaq
  • Market Cap
  • LCUT 133.4M
  • LPTX 117.1M
  • IPO Year
  • LCUT 1991
  • LPTX N/A
  • Fundamental
  • Price
  • LCUT $5.70
  • LPTX $2.74
  • Analyst Decision
  • LCUT Strong Buy
  • LPTX Strong Buy
  • Analyst Count
  • LCUT 2
  • LPTX 4
  • Target Price
  • LCUT $11.50
  • LPTX $8.63
  • AVG Volume (30 Days)
  • LCUT 70.8K
  • LPTX 452.0K
  • Earning Date
  • LCUT 11-07-2024
  • LPTX 11-13-2024
  • Dividend Yield
  • LCUT 2.98%
  • LPTX N/A
  • EPS Growth
  • LCUT N/A
  • LPTX N/A
  • EPS
  • LCUT N/A
  • LPTX N/A
  • Revenue
  • LCUT $670,888,000.00
  • LPTX N/A
  • Revenue This Year
  • LCUT $3.07
  • LPTX N/A
  • Revenue Next Year
  • LCUT $2.77
  • LPTX N/A
  • P/E Ratio
  • LCUT N/A
  • LPTX N/A
  • Revenue Growth
  • LCUT N/A
  • LPTX N/A
  • 52 Week Low
  • LCUT $5.25
  • LPTX $1.55
  • 52 Week High
  • LCUT $11.68
  • LPTX $5.00
  • Technical
  • Relative Strength Index (RSI)
  • LCUT 42.23
  • LPTX 39.77
  • Support Level
  • LCUT $5.78
  • LPTX $3.40
  • Resistance Level
  • LCUT $6.68
  • LPTX $3.61
  • Average True Range (ATR)
  • LCUT 0.29
  • LPTX 0.40
  • MACD
  • LCUT 0.00
  • LPTX -0.13
  • Stochastic Oscillator
  • LCUT 31.47
  • LPTX 1.91

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.

About LPTX Leap Therapeutics Inc.

Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .

Share on Social Networks: